科普蒂辛抑制了膀癌细胞的恶性瘤,并调节了XPO1的表达
1Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China.
Chemical biology & drug design
|July 13, 2023
概括
科普提辛 (COP) 有效地抑制了膀癌细胞的生长,迁移和侵入. 这种化合物向出口蛋白1 (XPO1),具有作为补充性膀癌症治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 膀癌表现出侵略性的生物行为,需要新的治疗策略.
- 确定药物开发的分子标对于改善膀癌治疗结果至关重要.
研究的目的:
- 为了研究皮素 (COP) 对膀癌细胞的抗癌作用.
- 阐明底层的分子机制,重点关注出口中的1 (XPO1) 条例.
主要方法:
- 膀癌细胞系以不同COP度进行体外治疗.
- 对细胞生长 (CCK-8),迁移 (划伤愈合),入侵 (Transwell) 和细胞循环 (流细胞计) 的检测.
- 生物信息学,定量实时PCR和西斑用于识别和量化XPO1表达和相关途径.
主要成果:
- 科普蒂辛显著抑制了膀癌细胞的增殖,迁移和入侵.
- 导出蛋白1 (XPO1) 被确定为COP的直接下游目标,COP治疗减少了XPO1的表达.
- 过度表达XPO1抵消了COP的抗癌作用,COP通过XPO1.1调节了环林D1和CYP450的作用.
结论:
- 科普蒂辛通过抑制XPO1表达,对膀癌细胞表现出强大的抗恶性活性.
- 作为膀癌的辅助治疗剂,COP显得有前途,通过XPO1调节准关键细胞过程.
相关概念视频
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


